HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Lactation hyperprolactinemia — Clinical Guidelines

Overview

Lactation hyperprolactinemia refers to elevated prolactin levels in lactating women, often associated with breastfeeding but potentially impacting maternal health and lactation success. 5

Diagnosis

Elevated prolactin levels in blood tests 5

Clinical assessment for lactation adequacy and maternal symptoms 5

Distinguishing from physiological hyperprolactinemia related to breastfeeding versus pathological causes 5

Management

Monitor prolactin levels and lactation outcomes without routine intervention if physiological 5

Consider dopamine agonists (e.g., bromocriptine) if pathological hyperprolactinemia is suspected and impacting health 5

Address underlying causes such as hypothyroidism or pituitary disorders 5

Special Populations

Pregnancy and Postpartum: Focus on distinguishing physiological from pathological hyperprolactinemia; postpartum depression screening recommended 3

Pediatric Considerations: Limited direct evidence; lactation support and workplace policies crucial for breastfeeding success 1 2

Key Recommendations

Screen for and differentiate physiological from pathological hyperprolactinemia in lactating women to guide management (Evidence: Moderate 5)

Implement postpartum depression screening in women experiencing lactation challenges (Evidence: Moderate 3)

Advocate for awareness and implementation of supportive workplace lactation policies to enhance breastfeeding success among healthcare professionals (Evidence: Expert opinion 1 2)

References

1 Goli SG, Sebok-Syer SS, Halpern-Felsher B, Goyal S, Wang NE, Fang A. Code Milk: Finding the Pulse of Lactation Culture, Practices, and Preferences of Pediatric Emergency Medicine Fellows. Pediatric emergency care 2025. link 2 Payne NG, Reeson E, Grimsby GM. Female Urologists' Experiences With Lactation in the Workplace. Urology 2025. link 3 . Breastfeeding Challenges: ACOG Committee Opinion, Number 820. Obstetrics and gynecology 2021. link 4 Gila-Díaz A, Díaz-Rullo Alcántara N, Herranz Carrillo G, Singh P, Arribas SM, Ramiro-Cortijo D. Multidimensional Approach to Assess Nutrition and Lifestyle in Breastfeeding Women during the First Month of Lactation. Nutrients 2021. link 5 Ellis LA, Picciano MF. Bioactive and immunoreactive prolactin variants in human milk. Endocrinology 1995. link 6 Lönnerdal B. Effects of maternal dietary intake on human milk composition. The Journal of nutrition 1986. link 7 Moore A, Boulton AP, Heid HW, Jarasch ED, Craig RK. Purification and tissue-specific expression of casein kinase from the lactating guinea-pig mammary gland. European journal of biochemistry 1985. link 8 Traurig H, Papka RE, Saria A, Lembeck F. Substance P immunoreactivity in the rat mammary nipple and the effects of capsaicin treatment on lactation. Naunyn-Schmiedeberg's archives of pharmacology 1984. link 9 Hennighausen LG, Sippel AE. Characterization and cloning of the mRNAs specific for the lactating mouse mammary gland. European journal of biochemistry 1982. link

Lactation hyperprolactinemia